The STREAM trial met its two-year statistical threshold, but more older adults assigned to stop statins experienced a heart attack, ischemic stroke or death.
A Phase 1a trial of CTX310, an experimental CRISPR-Cas9 gene-editing therapy from CRISPR Therapeutics, sustained a 52.5% mean LDL reduction and 47.8% triglyceride reduction for a full year in 15 patients — with no serious treatment-related adverse events — presented
Millions of Americans have their statin therapy calibrated to an LDL reading. A Northwestern University study in JAMA simulating 250,000 patients found that apolipoprotein B, which counts cholesterol particles rather than volume,
Millions of Americans have their statin therapy calibrated to an LDL reading. A Northwestern University study in JAMA simulating 250,000 patients found that apolipoprotein B, which counts cholesterol particles rather than volume,
Oxford researchers analysed 5.6 million patient records to build STRATIFY-StatinMD, showing more than 98% of statin-eligible patients face minimal serious muscle disorder risk. The finding confronts a treatment gap: over 60% of
A new study from the University of Oxford finds that more than 98 percent of statin-eligible patients face very low risk of serious muscle disorders. The STRATIFY-StatinMD calculator, built from 5.6 million
A Lancet study tracking nearly one million people across seven countries found that obese adults over 60 now show blood pressure and cholesterol profiles nearly identical to normal-weight peers, driven by widespread
A landmark 2026 Lancet study of 150,000 patients found 62 of 66 statin side effects on drug labels are not caused by the medication. Millions are stopping life-saving drugs over phantom risks.
Follow